Pages that link to "Q33932878"
Jump to navigation
Jump to search
The following pages link to Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites (Q33932878):
Displaying 50 items.
- Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity (Q24305397) (← links)
- Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin (Q24554531) (← links)
- Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA (Q27748892) (← links)
- Camptothecins: a review of their chemotherapeutic potential (Q28203339) (← links)
- Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors (Q28379464) (← links)
- DOSY NMR and MALDI-TOF evidence of covalent binding the DNA duplex by trimethylammonium salts of topotecan upon near UV irradiation (Q30960052) (← links)
- A study of 7-deaza-2'-deoxyguanosine 2'-deoxycytidine base pairing in DNA. (Q31128184) (← links)
- Inhibition of Flp recombinase by the topoisomerase I-targeting drugs, camptothecin and NSC-314622. (Q31816410) (← links)
- Topoisomerase-I inhibitors in gynecologic tumors (Q33541928) (← links)
- Towards Antitumor Active trans-Platinum Compounds (Q33649706) (← links)
- Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents (Q33951823) (← links)
- Natural triterpenoid avicins selectively induce tumor cell death (Q34054521) (← links)
- Sequence-specific interactions of drugs interfering with the topoisomerase-DNA cleavage complex (Q34707948) (← links)
- Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages (Q35047219) (← links)
- Avicins: triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation (Q35897882) (← links)
- Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove (Q36390575) (← links)
- Topoisomerase II-mediated site-directed alkylation of DNA by psorospermin and its use in mapping other topoisomerase II poison binding sites (Q36792820) (← links)
- A systematic study of nitrated indenoisoquinolines reveals a potent topoisomerase I inhibitor (Q36853889) (← links)
- Structural studies of type I topoisomerases (Q37108394) (← links)
- Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine (Q37258373) (← links)
- Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives (Q37760957) (← links)
- Different effects on human topoisomerase I by minor groove and intercalated deoxyguanosine adducts derived from two polycyclic aromatic hydrocarbon diol epoxides at or near a normal cleavage site (Q38292238) (← links)
- Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine (Q38326971) (← links)
- Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenine (Q38332699) (← links)
- Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I. (Q38347601) (← links)
- Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site. Implications for the role of lysine 136 in DNA binding (Q38351946) (← links)
- Luotonin A. A Naturally Occurring Human DNA Topoisomerase I Poison (Q40619958) (← links)
- Use of Chlamydomonas reinhardtii mutants for anticancer drug screening (Q40703900) (← links)
- Protein-Linked DNA Strand Breaks Induced by NSC 314622, a Novel Noncamptothecin Topoisomerase I Poison (Q41026765) (← links)
- Cellular resistance to camptothecins (Q41307850) (← links)
- A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons. (Q41622531) (← links)
- Mechanistic studies of the modulation of cleavage activity of topoisomerase I by DNA adducts of mono- and bi-functional PtII complexes (Q41857079) (← links)
- Potent Inhibitors of Human Immunodeficiency Virus Type 1 Integrase: Identification of a Novel Four-Point Pharmacophore and Tetracyclines as Novel Inhibitors (Q42545837) (← links)
- Mapping drug interactions at the covalent topoisomerase II-DNA complex by bisantrene/amsacrine congeners. (Q42677475) (← links)
- SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin (Q44221557) (← links)
- Some new bi- and ter-benzimidazole derivatives as topoisomerase I inhibitors (Q44485812) (← links)
- A mechanistic and kinetic study of the E-ring hydrolysis and lactonization of a novel phosphoryloxymethyl prodrug of camptothecin (Q44525190) (← links)
- Telomeric DNA damage by topoisomerase I. A possible mechanism for cell killing by camptothecin (Q44732917) (← links)
- DNA cleavage assay for the identification of topoisomerase I inhibitors (Q46312378) (← links)
- Molecular Modeling Studies of the DNA−Topoisomerase I Ternary Cleavable Complex with Camptothecin (Q47956236) (← links)
- Diversity of DNA topoisomerases I and inhibitors (Q48005418) (← links)
- Topoisomerase II site-directed alkylation of DNA by psorospermin and its effect on topoisomerase II-mediated DNA cleavage (Q52566841) (← links)
- Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. (Q53956545) (← links)
- DNA sequence selectivity of topoisomerases and topoisomerase poisons. (Q55067995) (← links)
- Effects of topoisomerase I inhibition on the expression of topoisomerase II alpha measured with fluorescence image cytometry (Q71771480) (← links)
- Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II study (Q73166093) (← links)
- Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes (Q73215656) (← links)
- Substitution of 5‐methylcytosines for cytosines enhances the stability of topoisomerase I‐DNA complexes and modulates the sequence selectivity of camptothecin‐induced DNA cleavage (Q74480895) (← links)
- Structural insights into the function of type IB topoisomerases (Q74520769) (← links)
- Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme (Q77333600) (← links)